The World Health Organization (WHO) has announced that vaccines against Mpox will soon be arriving in the Democratic Republic of Congo (DRC) amidst a surge in cases in the country and nearby regions. The vaccines, including donations from Danish drug maker Bavarian Nordic, are part of a global response to contain the outbreaks, which the WHO believes can be stopped within the next six months. This news comes after the disease, which has been present in Africa since 2022 but has seen a significant increase in cases due to more serious strains, was declared a global Public Health Emergency.
- The WHO Director-General announced that Mpox vaccines will soon arrive in DRC to combat the surge in cases.
- Tens of thousands of vaccine doses are ready to be dispatched, including 175,000 doses procured by HERA and an additional 40,000 doses donated by Bavarian Nordic.
- The WHO declared Mpox a global Public Health Emergency following an outbreak in DRC that spread to nearby countries including Burundi.
- More than 18,000 suspected Mpox cases have been recorded in DRC this year, with over 600 deaths reported.
- The current outbreak in Africa is caused by CA 1 and 1 B strains, which are considered more serious.
- Cases of Mpox have been reported beyond the African continent, including a recent case in Sweden.
France 24 is an international television network and news website owned by the French state.
Official website: https://www.france24.com/en/
Original video here.
This summary has been generated by AI.
